Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
157.1 USD | +0.05% | -8.39% | -12.60% |
Financials (USD)
Sales 2024 * | 638M | Sales 2025 * | 741M | Capitalization | 8.77B |
---|---|---|---|---|---|
Net income 2024 * | 43M | Net income 2025 * | 90M | EV / Sales 2024 * | 13.3 x |
Net cash position 2024 * | 276M | Net cash position 2025 * | 386M | EV / Sales 2025 * | 11.3 x |
P/E ratio 2024 * |
296
x | P/E ratio 2025 * |
103
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.41% |
Latest transcript on Repligen Corporation
1 day | +0.05% | ||
1 week | -8.39% | ||
Current month | -14.56% | ||
1 month | -20.91% | ||
3 months | -11.73% | ||
6 months | +7.42% | ||
Current year | -12.60% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 14-04-30 |
Olivier Loeillot
PSD | President | 54 | 23-10-01 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 23-09-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 05-08-31 |
Director/Board Member | 58 | 14-06-11 | |
Martin Madaus
BRD | Director/Board Member | 64 | 23-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.43% | 5 M€ | -1.80% | - | |
1.01% | 0 M€ | 0.00% | - | |
0.84% | 0 M€ | 0.00% | - | |
0.55% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 157.1 | +0.05% | 386,770 |
24-04-18 | 157.1 | -2.44% | 759,238 |
24-04-17 | 161 | -1.94% | 525,333 |
24-04-16 | 164.2 | -1.33% | 609,323 |
24-04-15 | 166.4 | -3.00% | 447,313 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.60% | 8.77B | |
-2.53% | 186B | |
-3.52% | 106B | |
+5.33% | 50.39B | |
+16.43% | 47.65B | |
-1.73% | 39.29B | |
+5.66% | 27.24B | |
-2.01% | 25.42B | |
+9.84% | 24.39B | |
-1.87% | 24.54B |
- Stock Market
- Equities
- RGEN Stock